Shares of N4 Pharma Plc (LON:N4P – Get Free Report) rose 15.5% during mid-day trading on Wednesday . The company traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.66 ($0.01). Approximately 336,244 shares were traded during trading, a decline of 72% from the average daily volume of 1,181,155 shares. The stock had previously closed at GBX 0.58 ($0.01).
N4 Pharma Price Performance
The company has a 50 day simple moving average of GBX 0.64 and a 200 day simple moving average of GBX 0.58. The company has a market capitalization of £2.62 million, a price-to-earnings ratio of -55.00 and a beta of -0.37. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than N4 Pharma
- What is the Euro STOXX 50 Index?
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Netflix Is On Track To Hit $1,000 By Christmas
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
